Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort

Carregando...
Imagem de Miniatura
Citações na Scopus
69
Tipo de produção
article
Data de publicação
2016
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
LANDI, Margarita
MALDONADO-FICCO, Hernan
PEREZ-ALAMINO, Rodolfo
MALDONADO-COCCO, Jose A.
CITERA, Gustavo
ARTURI, Pablo
ALVARADO, Diana E. Flores
BURGOS-VARGAS, Ruben
SANTOS, Elena
Citação
MEDICINE, v.95, n.51, article ID e5652, 6p, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The aim of the study was to compare clinical manifestations, disease activity, functional capacity, spinal mobility, and radiological findings between men and women from a multicenter, multiethnic Ibero-American cohort of patients with Spondyloarthritis (SpA). This observational cross-section study included 1264 consecutive SpA patients who fulfilled the modified New York criteria for ankylosing spondylitis (AS). Demographic, clinical, and radiologic data were evaluated. Categorical data were compared by chi(2) or Fisher's exact tests and continuous variables by ANOVA with post-hoc tests. Primary AS was diagnosed in 1072 patients, psoriatic spondylitis in 147, and spondylitis associated to inflammatory bowel disease (IBD) in 45 patients. Overall, male patients were significantly younger, had longer diagnostic delay, lower disease activity, worse spinal mobility, better quality of life, and more severe radiologic damage. Dactylitis and enthesitis, as well as swollen joint count, were significantly more common among women. In primary AS, there was a marked male predominance (76.2%). Among patients with psoriatic spondylitis, male predominance was lower (57.8%), but was also associated with worse spinal mobility and more severe radiologic damage. In the total population, male patients with primary AS referred higher permanent work disability (13.2% vs 6.9%; P<0.05), although no difference was observed in psoriatic or IBD spondylitis according to the gender. Among Ibero-American SpA patients, there are some differences in clinical and radiological manifestations, men showing more structural damage, whereas women more active disease. These data suggest that the phenotype of SpA differs between genders. This can influence the subsequent diagnostic approach and therapeutic decisions.
Palavras-chave
ankylosing spondylitis, gender differences, psoriatic spondylitis, spondyloarthritis
Referências
  1. Aloush V, 2007, RHEUMATOL INT, V27, P865, DOI 10.1007/s00296-007-0344-3
  2. Azevedo VF, 2010, REV BRAS REUMATOL, V50, P650
  3. Baraliakos X, 2011, CURR RHEUMATOL REP, V13, P383, DOI 10.1007/s11926-011-0192-8
  4. Barnabe C, 2012, J RHEUMATOL, V39, P1221, DOI 10.3899/jrheum.111393
  5. CALIN A, 1994, J RHEUMATOL, V21, P2281
  6. Ortega Castro R, 2013, REUMATOL CLIN, V9, P221
  7. Chandran V, 2010, J RHEUMATOL, V37, P4
  8. Chandran V, 2009, J RHEUMATOL, V36, P2744, DOI 10.3899/jrheum.090412
  9. Ciurea A, 2014, ANN RHEUM DIS, V73, P1908, DOI 10.1136/annrheumdis-2014-205613
  10. de Carvalho HMS, 2012, CLIN RHEUMATOL, V31, P687, DOI 10.1007/s10067-011-1890-3
  11. Dincer U, 2008, CLIN RHEUMATOL, V27, P457, DOI 10.1007/s10067-007-0727-6
  12. DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218, DOI 10.1002/art.1780341003
  13. Doward LC, 2003, ANN RHEUM DIS, V62, P20, DOI 10.1136/ard.62.1.20
  14. Eder L, 2013, ANN RHEUM DIS, V72, P578, DOI 10.1136/annrheumdis-2012-201357
  15. Feldtkeller E, 2000, CURR OPIN RHEUMATOL, V12, P239, DOI 10.1097/00002281-200007000-00002
  16. GARRETT S, 1994, J RHEUMATOL, V21, P2286
  17. Gladman Dafna D, 2007, Curr Rheumatol Rep, V9, P455, DOI 10.1007/s11926-007-0074-2
  18. GRAN JT, 1984, ANN RHEUM DIS, V43, P570, DOI 10.1136/ard.43.4.570
  19. Haglund E, 2011, ANN RHEUM DIS, V70, P943, DOI 10.1136/ard.2010.141598
  20. Ibn Yacoub Y, 2012, CLIN RHEUMATOL, V31, P293, DOI 10.1007/s10067-011-1819-x
  21. JONES SD, 1995, J RHEUMATOL, V22, P1609
  22. Lee W, 2008, ARTHRIT RHEUM-ARTHR, V59, P449, DOI 10.1002/art.23321
  23. Lee W, 2007, ANN RHEUM DIS, V66, P633, DOI 10.1136/ard.2006.060293
  24. Fernandez-Sueiro JL, 2009, ARTHRIT RHEUM-ARTHR, V61, P386, DOI 10.1002/art.24280
  25. Onen F, 2008, J RHEUMATOL, V35, P305
  26. Perez AR, 2011, J RHEUMATOL, V38, P1656, DOI 10.3899/JRHEUM.101049
  27. Queiro R, 2001, RHEUMATOL INT, V21, P66
  28. Queiro R, 2014, RHEUMATOLOGY, V53, P1178, DOI 10.1093/rheumatology/ket363
  29. Roussou E, 2011, CLIN RHEUMATOL, V30, P121, DOI 10.1007/s10067-010-1581-5
  30. Stolwijk C, 2012, RHEUM DIS CLIN N AM, V38, P441, DOI 10.1016/j.rdc.2012.09.003
  31. Taylor WJ, 2005, J RHEUMATOL, V32, P974
  32. Theander E, 2014, ANN RHEUM DIS, V73, P407, DOI 10.1136/annrheumdis-2012-201972
  33. Tillett W, 2012, RHEUMATOLOGY, V51, P275, DOI 10.1093/rheumatology/ker216
  34. Tournadre A, 2013, ARTHRIT CARE RES, V65, P1482, DOI 10.1002/acr.22001
  35. van der Horst-Bruinsma IE, 2013, ANN RHEUM DIS, V72, P1221, DOI 10.1136/annrheumdis-2012-202431
  36. van Tubergen A, 2003, ANN RHEUM DIS, V62, P140, DOI 10.1136/ard.62.2.140
  37. VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361
  38. Vazquez-Mellado J, 2008, REUMATOL CLIN, V4, P17
  39. Wallenius M, 2009, ANN RHEUM DIS, V68, P685, DOI 10.1136/ard.2008.092049
  40. Wanders AJB, 2004, ARTHRITIS RHEUM, V50, P2622, DOI 10.1002/art.20446